These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


292 related items for PubMed ID: 5539083

  • 1. Present status of measles and rubella immunization in the United States: a medical progress report.
    Krugman S.
    J Pediatr; 1971 Jan; 78(1):1-16. PubMed ID: 5539083
    [No Abstract] [Full Text] [Related]

  • 2. Present status of measles and rubella immunization in the United States: a medical progress report.
    Krugman S.
    J Pediatr; 1977 Jan; 90(1):1-12. PubMed ID: 12253
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Studies on live rubella vaccine. II. Field trials with two experimental vaccine strains.
    Minekawa Y, Suzuki N, Takahashi M, Okuno Y.
    Biken J; 1968 Dec; 11(4):243-50. PubMed ID: 5721530
    [No Abstract] [Full Text] [Related]

  • 5. [Recognition and immunoprophylaxis of measles and rubella].
    Zhang B, Ma L.
    Zhonghua Er Ke Za Zhi; 2020 Aug 02; 58(8):698-700. PubMed ID: 32842396
    [Abstract] [Full Text] [Related]

  • 6. Combined live measles-rubella virus vaccine. Findings in clinical laboratory studies.
    Villarejos VM, Arguedas JA, Buynak EB, Weibel RE, Stokes J, Hilleman MR.
    J Pediatr; 1971 Oct 02; 79(4):599-604. PubMed ID: 5094254
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [A comparative evaluation of the immunogenic activity of attenuated strains of rubella virus from the USA, Belgium and the USSR].
    Nifontova AI, Meshalova VN, Iakovleva NV, Smorodintsev AA.
    Vopr Virusol; 1970 Oct 02; 15(6):711-4. PubMed ID: 5518646
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunity after rubella and measles viral vaccines.
    Dudgeon JA.
    Am J Dis Child; 1978 Aug 02; 132(8):748-50. PubMed ID: 356586
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Indications for possibilities of preventive vaccination against measles and rubella].
    Siegert R.
    Internist (Berl); 1971 Aug 02; 12(8):309-12. PubMed ID: 4936452
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of a two-dose measles, mumps, and rubella vaccination schedule in a cohort of college athletes.
    Coté TR, Sivertson D, Horan JM, Lindegren ML, Dwyer DM.
    Public Health Rep; 1993 Aug 02; 108(4):431-5. PubMed ID: 8341775
    [Abstract] [Full Text] [Related]

  • 14. [The clinico-immunological evaluation of a bivalent vaccine against measles and rubella].
    Schettini F, Manzionna MM, De Mattia D, Amendola F, Di Bitonto G.
    Minerva Pediatr; 1990 Dec 02; 42(12):531-6. PubMed ID: 2087226
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Live attenuated rubella virus vaccines. Experiences with duck embryo cell preparations.
    Hilleman MR, Buynak EB, Whitman JE, Weibel RW, Stokes J.
    Am J Dis Child; 1969 Aug 02; 118(2):166-71. PubMed ID: 5815860
    [No Abstract] [Full Text] [Related]

  • 19. Experimental rubella studies. I. Clinical and laboratory features of infection caused by the Brown strain rubella virus. II. Artificial challenge studies of adult rubella vaccinees.
    Schiff GM, Donath R, Rotte T.
    Am J Dis Child; 1969 Aug 02; 118(2):269-74. PubMed ID: 5802433
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.